World's Best Scientists 2026 revealed!
Lars Wallentin

Lars Wallentin

Award Badge
Best Scientists
2025
Award Badge
Medicine
Sweden
2026

D-Index & Metrics

Best Scientists

D-Index
173
Citations
146312
World Ranking
760
National Ranking
12

Medicine

D-Index
174
Citations
154932
World Ranking
447
National Ranking
10

Research.com Recognitions

  • 2026 - Research.com Medicine in Sweden Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Medicine in Sweden Leader Award
  • 2023 - Research.com Medicine in Sweden Leader Award
  • 1998 - Nordic Medical Prize, SalusAnsvar/Ulf Nilsonnes Foundation for Medical Research

Overview

Lars Wallentin is affiliated with Uppsala University in Sweden and has made significant contributions in the field of medicine, particularly within cardiology and cardiovascular medicine. Their research output spans over 300 publications, with a focus on subfields including molecular biology, surgery, rheumatology, and radiology, nuclear medicine, and imaging.

The scientist's work primarily addresses topics related to cardiovascular health and disease management. Key research areas include:

  • Atrial Fibrillation Management and Outcomes
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Acute Myocardial Infarction Research
  • Cardiac Arrhythmias and Treatments
  • Cardiac Imaging and Diagnostics
  • GDF15 and Related Biomarkers
  • Heart Failure Treatment and Management

Lars Wallentin has contributed to numerous publications in several high-impact medical journals. Frequent venues for their work include:

  • European Heart Journal
  • Circulation
  • Journal of the American College of Cardiology
  • Journal of the American Heart Association
  • European Heart Journal - Quality of Care and Clinical Outcomes

Some of the recent papers featuring Lars Wallentin's research are:

  • "Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation," 2020, European Heart Journal
  • "Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease," 2020, Circulation
  • "Comparative Efficacy and Safety of Oral P2Y 12 Inhibitors in Acute Coronary Syndrome," 2020, Circulation
  • "Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals," 2020, Nature Metabolism
  • "Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets," 2023, Nature Immunology

Collaboration plays an important role in their work, with frequent co-authors including:

  • Christopher B. Granger
  • Agneta Siegbahn
  • Renato D. Lópes
  • Johan Lindbäck
  • Ziad Hijazi

Recognition for Lars Wallentin's contributions includes receiving the Nordic Medical Prize awarded by SalusAnsvar and the Ulf Nilsonnes Foundation for Medical Research in 1998.

Best Publications

  • Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

    Lars Wallentin;Richard C. Becker;Andrzej Budaj;Christopher P. Cannon

  • Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

    Elliott Antman;Jean-Pierre Bassand;Werner Klein;Magnus Ohman

  • Universal definition of myocardial infarction.

    Kristian Thygesen;Joseph S. Alpert;Harvey D. White;Allan S. Jaffe

  • Discovery and refinement of loci associated with lipid levels

    Cristen J. Willer;Ellen M. Schmidt;Sebanti Sengupta;Gina M. Peloso;Gina M. Peloso;Gina M. Peloso

  • Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction

    J. S. Alpert;E. Antman;F. Apple;P. W. Armstrong

  • Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes

    J.P. Bassand;C.W. Hamm;D. Ardissino;E. Boersma

  • Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.

    Bertil Lindahl;Henrik Toss;Agneta Siegbahn;Per Venge

  • Large-scale association analysis identifies new risk loci for coronary artery disease

    Panos Deloukas;Stavroula Kanoni;Christina Willenborg;Martin Farrall

  • Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden

    Bo Lagerqvist;Stefan K. James;Ulf Stenestrand;Johan Lindbäck

  • Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial

    John W. Eikelboom;Lars Wallentin;Stuart J. Connolly;Mike Ezekowitz

  • Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

    Micheal E. Bertrand;Maarten L. Simoons;Keith A.A. Fox;Lars C. Wallentin

  • Comparison of fondaparinux and enoxaparin in acute coronary syndromes.

    Salim Yusuf;Shamir R. Mehta;Susan Chrolavicius;Rizwan Afzal

  • Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: An analysis of the RE-LY trial

    Lars Wallentin;Salim Yusuf;Michael D Ezekowitz;Marco Alings

  • Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

    Eric Boersma;Robert A Harrington;David J Moliterno;Harvey White

  • Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

    John H. Jh Alexander;RD D Renato D. Rd Renato D Lopes;Stefan James;Rakhi Kilaru

  • Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial

    Yusuf S;Mehta;Chrolavicius S;Afzal R

  • Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials

    Francesco Costa;Francesco Costa;Francesco Costa;David van Klaveren;David van Klaveren;Stefan James;Dik Heg

  • A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS)

    D Hasdai;S Behar;L Wallentin;N Danchin

  • Routine vs Selective Invasive Strategies in Patients With Acute Coronary Syndromes: A Collaborative Meta-analysis of Randomized Trials

    Shamir R. Mehta;Christopher P. Cannon;Keith A. A. Fox;Lars Wallentin

  • The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).

    Paul A. Reilly;Thorsten Lehr;Sebastian Haertter;Stuart J. Connolly

Frequent Co-Authors

Agneta Siegbahn
Agneta Siegbahn Uppsala University
Stefan James
Stefan James Uppsala University
Christopher B. Granger
Christopher B. Granger Duke University
Renato D. Lopes
Renato D. Lopes Duke University
Claes Held
Claes Held Uppsala University
John H. Alexander
John H. Alexander Duke University
Robert F. Storey
Robert F. Storey University of Sheffield
Harvey D. White
Harvey D. White Auckland City Hospital
Robert A. Harrington
Robert A. Harrington Cornell University
Salim Yusuf
Salim Yusuf McMaster University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA opens up diverse opportunities beyond the traditional MD path. Many healthcare professionals enhance their expertise or shift their focus through specialized online degrees. For example, those interested in mental health may consider online msn pmhnp programs, which train nurses to provide psychiatric care—one of the fastest growing fields in healthcare.

If you’re passionate about leadership and organizational roles, an online healthcare administration degree offers affordable and flexible pathways to management positions in hospitals and healthcare organizations. Additionally, cost-conscious students may want to explore the cheapest master's in healthcare administration to further lower tuition expenses while gaining specialized skills.

For those aiming to reach the highest levels of advanced nursing, the cheapest dnp programs balance rigorous doctoral training with online accessibility. Each of these online health degrees can open new career doors, whether you plan to stay clinical, move into administration, or pursue research.

Best Scientists Citing Lars Wallentin

Trending Scientists